Pacira BioSciences, Inc.
PCRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $277 | $153 | $104 | $586 |
| Short-Term Investments | $208 | $125 | $185 | $71 |
| Receivables | $113 | $106 | $98 | $96 |
| Inventory | $125 | $104 | $96 | $99 |
| Other Curr. Assets | $22 | $22 | $15 | $15 |
| Total Curr. Assets | $745 | $510 | $498 | $866 |
| Property Plant & Equip (Net) | $216 | $235 | $254 | $265 |
| Goodwill | $0 | $163 | $163 | $145 |
| Intangibles | $426 | $483 | $541 | $624 |
| Long-Term Investments | $29 | $2 | $37 | $0 |
| Tax Assets | $130 | $144 | $160 | $153 |
| Other NC Assets | $6 | $36 | $27 | $22 |
| Total NC Assets | $808 | $1,064 | $1,183 | $1,209 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,554 | $1,574 | $1,681 | $2,075 |
| Liabilities | – | – | – | – |
| Payables | $19 | $16 | $15 | $11 |
| Short-Term Debt | $211 | $17 | $43 | $383 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $80 | $64 | $90 | $128 |
| Total Curr. Liab. | $310 | $97 | $148 | $521 |
| LT Debt | $428 | $569 | $721 | $746 |
| Deferred Rev, NC | $0 | $0 | $0 | $10 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $37 | $38 | $38 | $67 |
| Total NC Liab. | $465 | $607 | $758 | $824 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $54 | $64 | $74 | $80 |
| Total Liabilities | $775 | $704 | $906 | $1,345 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$206 | -$107 | -$149 | -$212 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $984 | $977 | $924 | $942 |
| Total Equity | $778 | $870 | $775 | $730 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,554 | $1,574 | $1,681 | $2,075 |
| Net Debt | $362 | $433 | $659 | $543 |